Presented by Dr. Shabir Madhi and Narrated by Clare Cutland
Measurable Learning Objectives:
At the conclusion of this presentation, participants should be able to…
1. Understand that informed decision making on tools to prevent stillbirths requires systematic investigation of the cases.
2. Describe foetal invasive bacterial disease as a leading cause of stillbirth in low-middle income settings, including due to GBS, E. coli and Enterococcus sp.
:ABOUT THE PRESENTER:
Shabir Madhi, MBBCh, FCPaeds, MMed, PhD
Shabir Madhi is Professor of Vaccinology at University of the Witwatersrand in Johannesburg, South Africa His current research interests includes the epidemiology of GBS disease and clinical development of GBS vaccines, and include the first studies on a trivalent GBS conjugate vaccine in pregnant women.
Clare Cutland, MBBCH, PhD
Dr. Clare Cutland is the deputy director of the Respiratory and Meningeal Pathogens Research Unit (RMPRU) based at Chris Hani Baragwanath Academic Hospital (CHBAH), Soweto, South Africa. She qualified with a Bachelor in Science (B.Sc. 1993) and Bachelor of Medicine and Surgery (MBBCh 1997) from The University of the Witwatersrand (Wits), Johannesburg, South Africa. After completing a Diploma in Child Health (DCH 2000), she joined RMPRU as a full time research doctor, under Professor Shabir Madhi. She has been an investigator on numerous phase I, II and III paediatric and maternal vaccine trials and principal investigator on a phase II paediatric measles vaccine trial, a phase III quadrivalent influenza vaccine trial in children and a phase III maternal influenza immunization trial in HIV-positive women.